AI company Tempus secures $1.1 billion in data agreements with leading pharmaceutical firms
Tempus AI Reports Record Growth and Customer Engagement 2026/01/11 – 5:30 PM Tempus AI, Inc. has shared preliminary, unaudited data showcasing a substantial revenue of approximately $316 million for the year 2025. This marks a 31% increase from the previous year, driven notably by a 38% growth in their Insight (data license) segment. The net […]